参考文献:1. Lopez, AD, Mathers, CD, Ezzati, M, Jamison, DT, Murray, CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: pp. 1747-1757 CrossRef 2. Mancia, G, Laurent, S, Agabiti-Rosei, E, Ambrosioni, E, Burnier, M, Caulfield, MJ, Cifkova, R, Cl茅ment, D, Coca, A, Dominiczak, A (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27: pp. 2121-2158 CrossRef 3. Raj, M, Krishnakumar, R (2013) Hypertension in children and adolescents: epidemiology and pathogenesis. Indian J Pediatr 80: pp. S71-S76 CrossRef 4. Hart, JL (2011) Role of sulfur-containing gaseous substances in the cardiovascular system. Front Biosci (Elite Ed) 3: pp. 736-749 CrossRef 5. Zoccali, C, Catalano, C, Rastelli, S (2009) Blood pressure control: hydrogen sulfide, a new gasotransmitter, takes stage. Nephrol Dial Transplant 24: pp. 1394-1396 CrossRef 6. Kabil, O, Banerjee, R (2010) Redox biochemistry of hydrogen sulfide. J Biol Chem 285: pp. 21903-21907 CrossRef 7. Shibuya, N, Mikami, Y, Kimura, Y, Nagahara, N, Kimura, H (2009) Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 146: pp. 623-626 CrossRef 8. Alexander, SP, Mathie, A, Peters, JA (2008) Guide to receptors and channels (GRAC), 3rd edition. Br J Pharmacol 153: pp. S1-S209 CrossRef 9. Yan, H, Du, J, Tang, C (2004) The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 313: pp. 22-27 CrossRef 10. 艁owicka, E, Be艂towski, J (2007) Hydrogen sulfide (H2S)鈥攖he third gas of interest for pharmacologists. Pharmacol Rep 59: pp. 4-24 11. Prabha, M, Jin, HF, Tian, Y, Tang, CS, Du, JB (2008) Mechanisms responsible for pulmonary hypertension. Chin Med J 121: pp. 2604-2609 12. Szab贸, C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: pp. 917-935 CrossRef 13. Tang, C, Li, XH, Du, JB (2006) Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr Vasc Pharmacol 4: pp. 17-22 CrossRef 14. Yang, G, Wu, L, Jiang, B, Yang, W, Qi, J, Cao, K, Meng, Q, Mustafa, AK, Mu, W, Zhang, S (2008) H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: pp. 587-590 CrossRef 15. Yeager, ME, Halley, GR, Golpon, HA, Voelkel, NF, Tuder, RM (2001) Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 88: pp. 2-11 CrossRef 16. Zhu, P, Huang, L, Ge, X, Yan, F, Wu, R, Ao, Q (2006) Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling. Int J Exp Pathol 87: pp. 463-474 CrossRef 17. Mustafa, AK, Sikka, G, Gazi, SK, Steppan, J, Jung, SM, Bhunia, AK, Barodka, VM, Gazi, FK, Barrow, RK, Wang, R (2011) Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res 109: pp. 1259-1268 CrossRef 18. Noma, A (1983) ATP-regulated K+ channels in cardiac muscle. Nature 305: pp. 147-148 CrossRef 19. Quayle, JM, Nelson, MT, Standen, NB (1997) ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77: pp. 1165 20. Yang, Y, Shi, Y, Guo, S, Zhang, S, Cui, N, Shi, W, Zhu, D, Jiang, C (2008) PKA-dependent activation of the vascular smooth muscle isoform of KATP channels by vasoactive intestinal polypeptide and its effect on relaxation of the mesenteric resistance artery. Biochim Biophys Acta 1778: pp. 88-96 CrossRef 21. Mannhold, R (2004) KATP channel openers: structure-activity relationships and therapeutic potential. Med Res Rev 24: pp. 213-266 CrossRef 22. Jin, HF, Du, JB, Tang, CS (2010) 鈥淲aste gas is not waste鈥? advance in the research of hydrogen sulfide. Acta Physiol Sin 62: pp. 495-504 23. Kajimura, M, Fukuda, R, Bateman, RM, Yamamoto, T, Suematsu, M (2010) Intractions of multiple gas-transducing systems: hallmarks and uncertainties of CO, NO, and H2S gas biology. Antioxid Redox Signal 13: pp. 157-192 CrossRef 24. Miller, TW, Isenberg, JS, Roberts, DD (2009) Molecular regulation of tumor angiogenesis and perfusion via redox signaling. Chem Rev 109: pp. 3099-3124 CrossRef 25. Walford, G, Loscalzo, J (2003) Nitric oxide in vascular biology. J Thromb Haemost 1: pp. 2112-2118 CrossRef 26. Skovgaard, N, Gouliaev, A, Aalling, M, Simonsen, U (2011) The role of endogenous H2S in cardiovascular physiology. Curr Pharm Biotechnol 12: pp. 1385-1393 CrossRef 27. Hosoki, R, Matsuki, N, Kimura, H (1997) The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237: pp. 527-531 CrossRef 28. Zhao, W, Zhang, J, Lu, Y, Wang, R (2001) The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20: pp. 6008-6016 CrossRef 29. Fujita, A, Kurachi, Y (2000) Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system and K+ channel openers. Pharmacol Ther 85: pp. 39-53 CrossRef 30. Lu, C, Halvorsen, SW (1997) Channel activators regulate ATP-sensitive potassium channel (kir6.1) expression in chick cardiomyocytes. FEBS Lett 412: pp. 121-125 CrossRef 31. Miki, T, Suzuki, M, Shibasaki, T, Uemura, H, Sato, T, Yamaguchi, K, Koseki, H, Iwanaga, T, Nakaya, H, Seino, S (2002) Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 8: pp. 466-472 CrossRef 32. Blanco-Rivero, J, Gamallo, C, Aras-L贸pez, R, Cobe帽o, L, Cogolludo, A, P茅rez-Vizcaino, F, Ferrer, M, Balfagon, G (2008) Decreased expression of aortic KIR6.1 and SUR2B in hypertension does not correlate with changes in the functional role of K(ATP) channels. Eur J Pharmacol 587: pp. 204-208 CrossRef 33. Philip-Couderc, P, Tavares, NI, Roatti, A, Lerch, R, Montessuit, C, Baertschi, AJ (2008) Forkhead transcription factors coordinate expression of myocardial KATP channel subunits and energy metabolism. Circ Res 102: pp. e20-e35 CrossRef 34. Whitfield, NL, Kreimier, EL, Verdial, FC, Skovgaard, N, Olson, KR (2008) Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol 294: pp. R1930-R1937 CrossRef 35. Xie, L, Tiong, CX, Bian, JS (2012) Hydrogen sulfide protects SH-SY5Y cells against 6-hydroxydopamine-induced endoplasmic reticulum stress. Am J Physiol Cell Physiol 303: pp. C81-C91 CrossRef 36. Zhao, W, Wang, R (2002) H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283: pp. 474-480 CrossRef 37. Ingenbleek, Y, Kimura, H (2013) Nutritional essentiality of sulfur in health and disease. Nutr Rev 71: pp. 413-432 CrossRef 38. Kimura, H (2014) Production and physiological effects of hydrogen sulfide. Antioxid Redox Signal 20: pp. 783-793 CrossRef 39. Lohmeier, TE (2002) Neurohumoral regulation of arterial pressure in hemorrhage and heart failure. Am J Physiol Regul Integr Comp Physiol 283: pp. R810-R814 CrossRef 40. Be艂towski, J (2010) Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. J Pharmacol Exp Ther 334: pp. 358-363 CrossRef 41. Liew, HC, Khoo, HE, Moore, PK, Bhatia, M, Lu, J, Moochhala, SM (2007) Synergism between hydrogen sulfide (H2S) and nitric oxide (NO) in vasorelaxation induced by stonustoxin (SNTX), a lethal and hypotensive protein factor isolated from atonefish synanceia horrida venom. Life Sci 80: pp. 1664-1668 CrossRef 42. Lee, SW, Cheng, Y, Moore, PK, Bian, JS (2007) Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells. Biochem Biophys Res Commun 358: pp. 1142-1147 CrossRef 43. Weimin, Z, Jing, Z, Yanjie, L, Rui, W (2001) The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20: pp. 6008-6016 CrossRef 44. Schreier, B, Rabe, S, Schneider, B, Bretschneider, M, Rupp, S, Ruhs, S, Neumann, J, Rueckschloss, U, Sibilia, M, Gotthardt, M (2013) Loss of epidermal growth factor receptor in vascular smooth muscle cells and cardiomyocytes causes arterial hypotension and cardiac hypertrophy. Hypertension 61: pp. 333-340 CrossRef 45. Zhang, Y, Guan, Y, Schneider, A, Brandon, S, Breyer, RM, Breyer, MD (2000) Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors. Hypertension 35: pp. 1129-1134 CrossRef 46. Butz, GM, Davisson, RL (2001) Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics 5: pp. 89-97 47. Yamamoto, K, Sokabe, T, Matsumoto, T, Yoshimura, K, Shibata, M, Ohura, N, Fukuda, T, Sato, T, Sekine, K, Kato, S (2006) Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 12: pp. 133-137 CrossRef
刊物类别:Biomedical and Life Sciences
刊物主题:Biomedicine Molecular Medicine Internal Medicine